Rasiq Ahmed, MD
Pediatric Medicine · Pasadena, CANPI 1033394408
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $256, 4.6 times the $56 reported in 2019. Among pediatric medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$227
- Organon$173
- Merck$152
- Novo Nordisk$86
- Sanofi Pasteur Inc.$65
- Boehringer Ingelheim$64
- plus $201 from 7 others
What the payments were for
- Food & beverage$969100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 12 | $227 |
| Organon | 10 | $173 |
| Merck | 9 | $152 |
| Novo Nordisk | 4 | $86 |
| Sanofi Pasteur Inc. | 3 | $65 |
| Boehringer Ingelheim | 3 | $64 |
| Lilly USA, LLC | 3 | $57 |
| Hologic Sales And Service, LLC | 2 | $41 |
| Exact Sciences | 1 | $25 |
| Myovant Sciences Inc. | 1 | $25 |
| Pfizer | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $18 |
| Bayer | 1 | $12 |
How this compares
$969 in reported general payments places this provider in the 95th percentile of 52 pediatric medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $425 |
| Gabapentin | 15 | $77 |
| Promethazine Hcl | 12 | $74 |
| Atorvastatin Calcium | 11 | $69 |
| Hydrochlorothiazide | 25 | $63 |
| Naproxen | 12 | $60 |
| Amoxicillin | 13 | $27 |
| Azithromycin | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other pediatric medicine in Pasadena
- Ulrike ZiegnerRedondo Beach$29K
- Edgar FloresFullerton$13K
- Trach DangSan Jose$451
- Nirmita DoshiOakland$0
- Joyce ArpilledaSan Diego$0
- Anna EkstromFremont$0
- Patricia TanseyElk Grove$0
- Margaret KhouryBaldwin Park$0
- Charles PohlWest Hollywood$0
- Allan MarksSan Francisco$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.